MedTrace Logo

Therapeutic Drug Monitoring of Fluconazole in Critically Ill Patients

NCT04252027 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 43

Last updated 2021-04-28

No results posted yet for this study

Summary

This prospective study will research the exposure and its variability to fluconazole after longitudinal administration in critically ill patients

Conditions

  • Critically Ill Patients

Interventions

OTHER

Sample collection

Plasma and urine sample collection

Sponsors & Collaborators

  • KU Leuven

    collaborator OTHER

  • Universitaire Ziekenhuizen KU Leuven

    lead OTHER

Principal Investigators

  • Isabel Spriet, PharmD, PhD · UZ Leuven

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-23
Primary Completion
2020-03-05
Completion
2020-03-05

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04252027 on ClinicalTrials.gov